What is Sequetech?
Sequetech specializes in providing comprehensive sequencing services, catering to a wide array of template types including Plasmids, M13 clones, and PCR products. The company also offers a distinctive oligonucleotide sequencing service for the verification of synthetic DNA production lots. With a commitment to superior customer service, rapid turnaround times, and high-quality data, Sequetech has cultivated a loyal customer base. Their experienced staff manages sequencing projects of all scales, enabling researchers to optimize their time and focus on core scientific endeavors. This dedication positions Sequetech as a leader in the genomics and biotechnology research support industry.
How much funding has Sequetech raised?
Sequetech has raised a total of $766K across 2 funding rounds:
Debt
$350K
Debt
$416K
Debt (2020): $350K with participation from PPP
Debt (2021): $416K led by PPP
Key Investors in Sequetech
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Sequetech?
The recent major strategic investment signals a pivotal growth phase for Sequetech. This capital infusion is expected to fuel expansion initiatives, potentially including the enhancement of service offerings, scaling of operational capacity, and further development of proprietary sequencing technologies. The company's focus on quality and customer satisfaction, combined with this significant financial backing, positions Sequetech for accelerated market penetration and leadership in the competitive field of molecular biology services. Future developments may also involve strategic partnerships to broaden their reach and impact within the scientific community.
See full Sequetech company page
